Park Place Capital Corp Acquires 1,486 Shares of Chemed Corporation (NYSE:CHE)

Park Place Capital Corp boosted its stake in Chemed Corporation (NYSE:CHE - Free Report) by 71.2% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,572 shares of the company's stock after acquiring an additional 1,486 shares during the period. Park Place Capital Corp's holdings in Chemed were worth $2,198,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Raymond James Financial Inc. acquired a new stake in Chemed during the fourth quarter worth approximately $42,023,000. Synergy Asset Management LLC boosted its holdings in shares of Chemed by 108.4% during the 1st quarter. Synergy Asset Management LLC now owns 3,049 shares of the company's stock worth $1,876,000 after buying an additional 1,586 shares in the last quarter. Silver Oak Securities Incorporated acquired a new stake in shares of Chemed during the 1st quarter worth approximately $309,000. Farther Finance Advisors LLC grew its position in shares of Chemed by 23.0% during the 1st quarter. Farther Finance Advisors LLC now owns 150 shares of the company's stock worth $93,000 after buying an additional 28 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its stake in shares of Chemed by 10.9% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 136,182 shares of the company's stock valued at $72,149,000 after acquiring an additional 13,394 shares in the last quarter. Institutional investors and hedge funds own 95.85% of the company's stock.

Wall Street Analyst Weigh In

CHE has been the topic of several research analyst reports. Wall Street Zen raised shares of Chemed from a "hold" rating to a "buy" rating in a research note on Friday, March 7th. Royal Bank Of Canada increased their price objective on shares of Chemed from $667.00 to $674.00 and gave the stock an "outperform" rating in a research report on Monday, April 28th.

Chemed Stock Up 0.8%

Shares of NYSE:CHE opened at $556.74 on Friday. Chemed Corporation has a twelve month low of $512.12 and a twelve month high of $623.61. The stock's 50 day moving average is $564.94 and its 200-day moving average is $564.75. The firm has a market capitalization of $8.15 billion, a price-to-earnings ratio of 27.12, a PEG ratio of 2.30 and a beta of 0.54.

Chemed (NYSE:CHE - Get Free Report) last announced its quarterly earnings results on Wednesday, April 23rd. The company reported $5.63 EPS for the quarter, beating analysts' consensus estimates of $5.59 by $0.04. The business had revenue of $646.94 million during the quarter, compared to analyst estimates of $641.78 million. Chemed had a net margin of 12.40% and a return on equity of 27.58%. Chemed's quarterly revenue was up 9.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $5.20 EPS. Equities research analysts anticipate that Chemed Corporation will post 21.43 earnings per share for the current fiscal year.

Chemed Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 17th. Shareholders of record on Thursday, May 29th were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 0.36%. The ex-dividend date of this dividend was Thursday, May 29th. Chemed's dividend payout ratio is currently 9.74%.

Insider Transactions at Chemed

In related news, CEO Kevin J. Mcnamara sold 1,000 shares of the firm's stock in a transaction dated Monday, March 31st. The shares were sold at an average price of $615.33, for a total transaction of $615,330.00. Following the transaction, the chief executive officer now directly owns 101,679 shares of the company's stock, valued at $62,566,139.07. This trade represents a 0.97% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Spencer S. Lee sold 1,500 shares of the company's stock in a transaction dated Wednesday, May 7th. The stock was sold at an average price of $577.86, for a total transaction of $866,790.00. Following the completion of the sale, the executive vice president now directly owns 16,127 shares of the company's stock, valued at $9,319,148.22. The trade was a 8.51% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 5,500 shares of company stock valued at $3,213,780 over the last ninety days. 3.29% of the stock is currently owned by insiders.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.